sales

Showing 15 posts of 91 posts found.

Witty image

GSK’s Witty loses bonus over China scandal

February 28, 2014
Medical Communications, Sales and Marketing China, GSK, Witty, sales, sir andrew

GlaxoSmithKline’s chief executive Sir Andrew Witty received bonuses “lower than they otherwise might have been” last year due to the …

Sanofi’s chief executive Christopher Viehbacher image

Analysts ‘disappointed’ by Sanofi guidance

February 6, 2014
Sales and Marketing Aubagio, Plavix, Sanofi, q4, sales

Sanofi has announced a mixed bag for its full year results as analysts have questioned why its forecasts for the …

Sales rise for Novartis

January 30, 2014
Sales and Marketing Gleevec, Glivec, Novartis, gilenya, q4, sales

Multiple sclerosis drug Gilenya, with sales rising 62% year-on-year to $1.9 billion, was one of the stars of last year …

maze image

Thought leader mapping: do we need a radical rethink?

January 13, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Havas, bartley, marketing, sales, thought leader

The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …

GSK image

GSK changes sales tactics

December 17, 2013
Medical Communications, Sales and Marketing GSK, Witty, bribery, corruption, cuts, sales, transparency

GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products.  The UK …

Merck image

Merck sees sales dip

July 31, 2013
Sales and Marketing Merck, Q2, Singulair, sales

A catastrophic decline in sales of asthma medicine Singulair is among the key reasons why Merck’s pharma revenue fell 12% …

J&J image

J&J sees Q2 sales rise

July 17, 2013
Sales and Marketing Elan, J&J, JJ, Q2, Synthes, sales

Johnson & Johnson saw overall sales rise 8.5% year-on-year in the second quarter of 2013, with the US healthcare group …

‘Solid’ start for Novartis

April 30, 2013
Sales and Marketing Novartis, Q1, sales

Novartis’ sales of pharma products were unchanged in the first quarter of 2013 at $7.9 billion, with pricing flat, the …

What Does E-Detailing Entail? How E-Detailing is Shaping the Pharmaceutical Industry

August 7, 2012
Sales and Marketing e-detailing, sales, sales reps

E-detailing has come at a time of great change in the pharmaceutical industry. The economic recession hit hard with pressure …

Success Factors in Value Communication Design – Introduction

July 12, 2012
Sales and Marketing interactive apps, sales, value, value communications

This is the introductory article to the ‘Success Factors in Value Communication Design’ series; a set of articles that examine and explain …

China driving global pharma growth

October 13, 2010
Sales and Marketing China, emerging markets, sales

The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …

Doctors.net.uk Strengthens Pharmaceutical Team

August 5, 2010
Sales and Marketing Doctors.net.uk, GPs, doctors, marketing, medeconnect, pharma, sales

Doctors.net.uk, the UK’s largest and most active online network of healthcare professionals, has strengthened its pharmaceutical team with two appointments.  …

Pfizer still at number 1, but Lipitor to slip

May 4, 2010
Sales and Marketing Humira, Lipitor, Pfizer, sales

New research suggests that the pharma world is going to be shaken up over the next few years – although …

Brazil

Emerging Markets: finding your way in a Brave New World

March 1, 2010
Sales and Marketing Brazil, China, India, Russia, em, emerging markets, sales, sales force effectiveness

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …

Sights set on target setting?

February 16, 2010
Sales and Marketing forecasts, sales

Research funded by the Chartered Institue of Management Accountants (CIMA) has helped Cranfield School of Management unveil a new framework …

The Gateway to Local Adoption Series

Latest content